(Q46169452)

20 December 2017

title

Responsiveness to levodopa in epsilon-sarcoglycan deletions (English)

1 reference

20 December 2017

1 reference

Rachel Saunders-Pullman

6

object named as

Rachel Saunders-Pullman

1 reference

20 December 2017

4

Deborah Raymond

1 reference

20 December 2017

Laurie Ozelius

2

object named as

Laurie Ozelius

1 reference

20 December 2017

author name string

Marta San Luciano

1

1 reference

20 December 2017

Katherine Sims

3

1 reference

20 December 2017

Liu Liu

5

1 reference

20 December 2017

language of work or name

English

0 references

publication date

1 February 2009

1 reference

20 December 2017

published in

Movement Disorders

1 reference

20 December 2017

volume

24

1 reference

20 December 2017

issue

3

1 reference

20 December 2017

page(s)

425-428

1 reference

20 December 2017

Myoclonus dystonia: possible association with obsessive-compulsive disorder and alcohol dependence.

cites work

1 reference

Myoclonus-dystonia syndrome: epsilon-sarcoglycan mutations and phenotype

21 January 2018

1 reference

Localization of a gene for myoclonus-dystonia to chromosome 7q21-q31

21 January 2018

1 reference

A pilot tolerability and efficacy trial of sodium oxybate in ethanol-responsive movement disorders

21 January 2018

1 reference

21 January 2018

1 reference

Limited efficacy of levetiracetam on myoclonus of different etiologies

21 January 2018

1 reference

Clinical, biochemical, and physiological features distinguishing myoclonus responsive to 5-hydroxytryptophan, tryptophan with a monoamine oxidase inhibitor, and clonazepam

21 January 2018

1 reference

Deep brain stimulation in myoclonus-dystonia syndrome

21 January 2018

1 reference

Pallidal stimulation relieves myoclonus-dystonia syndrome.

21 January 2018

1 reference

Myoclonus, motor deficits, alterations in emotional responses and monoamine metabolism in epsilon-sarcoglycan deficient mice.

21 January 2018

1 reference

Myoclonus-dystonia due to genomic deletions in the epsilon-sarcoglycan gene.

21 January 2018

1 reference

SGCE missense mutations that cause myoclonus-dystonia syndrome impair epsilon-sarcoglycan trafficking to the plasma membrane: modulation by ubiquitination and torsinA

21 January 2018

1 reference

Clinical and genetic features of myoclonus-dystonia in 3 cases: a video presentation

21 January 2018

1 reference

Genomic deletion size at the epsilon-sarcoglycan locus determines the clinical phenotype

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MDS.22375

1 reference

20 December 2017

PubMed ID

19133653

1 reference

20 December 2017